Terumo Co. (OTCMKTS:TRUMY - Get Free Report) shares crossed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $18.82 and traded as low as $17.63. Terumo shares last traded at $17.94, with a volume of 140,281 shares trading hands.
Terumo Trading Down 0.1%
The company has a 50-day simple moving average of $18.82 and a 200-day simple moving average of $18.94. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.70 and a current ratio of 2.94. The stock has a market cap of $26.56 billion, a P/E ratio of 34.50 and a beta of 0.80.
Terumo (OTCMKTS:TRUMY - Get Free Report) last issued its quarterly earnings data on Wednesday, May 14th. The company reported $0.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.15 by ($0.07). The business had revenue of $1.79 billion during the quarter, compared to analysts' expectations of $1.79 billion.
About Terumo
(
Get Free Report)
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Terumo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Terumo wasn't on the list.
While Terumo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.